Viewing Study NCT04247256


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2026-02-26 @ 11:15 AM
Study NCT ID: NCT04247256
Status: UNKNOWN
Last Update Posted: 2022-03-02
First Post: 2020-01-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
Sponsor: Scandion Oncology A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module